Related references
Note: Only part of the references are listed.SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway
Chi-Yu Kuo et al.
ENDOCRINE-RELATED CANCER (2022)
Regulation of Expression of Sterol Regulatory Element-binding Protein 1 in Thyroid Cancer Cells
Tung-Sun Huang et al.
ANTICANCER RESEARCH (2022)
Transcriptomic Characteristics Associated With Aging in the Thyroid Gland
Chien-Liang Liu et al.
FRONTIERS IN NUTRITION (2022)
ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells
Shou-Sen Huang et al.
ENDOCRINE (2022)
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis
Jacob Haase et al.
MODERN PATHOLOGY (2021)
Higher Integrin Alpha 3 Beta1 Expression in Papillary Thyroid Cancer Is Associated with Worst Outcome
Lorenza Mautone et al.
CANCERS (2021)
Integrin β4 Is an Effective and Efficient Marker in Synchronously Highlighting Lymphatic and Blood Vascular Invasion, and Perineural Aggression in Malignancy
Jian Li et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression
Samir Devalaraja et al.
CELL (2020)
Redifferentiation of radioiodine-refractory thyroid cancers
Camille Buffet et al.
ENDOCRINE-RELATED CANCER (2020)
Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer
Shih-Ping Cheng et al.
JOURNAL OF PATHOLOGY (2020)
Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes
Giulia Sapuppo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Crabp2 Promotes Metastasis of Lung Cancer Cells via HuR and Integrin β1/FAK/ERK Signaling
Jun-I Wu et al.
SCIENTIFIC REPORTS (2019)
Radioactive iodine in differentiated thyroid cancer: a national database perspective
Ryan K. Orosco et al.
ENDOCRINE-RELATED CANCER (2019)
CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status
Xuefei Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
Laura Fugazzola et al.
EUROPEAN THYROID JOURNAL (2019)
Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells
Yi-Tian Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Response of Retinoic Acid in Patients with Radioactive Iodine-Refractory Thyroid Cancer: A Meta-Analysis
Kyoungjune Pak et al.
ONCOLOGY RESEARCH AND TREATMENT (2018)
Identification of influential proteins in the classical retinoic acid signaling pathway
Hamed Ghaffari et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2018)
Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy
Viera Dobrotkova et al.
BMC CANCER (2018)
Overexpression of teneurin transmembrane protein 1 is a potential marker of disease progression in papillary thyroid carcinoma
Shih-Ping Cheng et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2017)
Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma
Jie-Jen Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases
Joseph L. Napoli
PHARMACOLOGY & THERAPEUTICS (2017)
CD74 expression and its therapeutic potential in thyroid carcinoma
Shih-Ping Cheng et al.
ENDOCRINE-RELATED CANCER (2015)
Expression of haem oxygenase-1 correlates with tumour aggressiveness and BRAFV600E expression in thyroid cancer
Tao-Yeuan Wang et al.
HISTOPATHOLOGY (2015)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
CRABP-II is a highly sensitive and specific diagnostic molecular marker for pancreatic ductal adenocarcinoma in distinguishing from benign pancreatic conditions
Wenbin Xiao et al.
HUMAN PATHOLOGY (2014)
Cellular Retinoic Acid-binding Protein 2 Inhibits Tumor Growth by Two Distinct Mechanisms
Amanda C. Vreeland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer
Sonal Gupta et al.
CLINICAL CANCER RESEARCH (2012)
Retinoid X receptor γ up-regulation is correlated with dedifferentiation of tumor cells and lymph node metastasis in papillary thyroid carcinoma
Zhiyan Liu et al.
PATHOLOGY INTERNATIONAL (2011)
Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells
Jeong-Hoon Lee et al.
CANCER LETTERS (2010)
Retinoic acid receptor and retinoid X receptor subtype expression for the differential diagnosis of thyroid neoplasms
Hendrieke C. Hoftijzer et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for β-catenin and Notch signalling
Charlotte A. Collins et al.
DEVELOPMENTAL BIOLOGY (2008)
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors
Thaddeus T. Schug et al.
CELL (2007)
All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor β messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes
R Elisei et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Share Paper
